Reference
Ariel Stern (Harvard Business School), “Regulatory Incentives for Innovation: The FDA’s Breakthrough Therapy Designation”, Workshop: Innovation, regulation and organization in healthcare, Paris, 2022.
See also
Published in
Workshop: Innovation, regulation and organization in healthcare, Paris, 2022